Liu J-G, Wang H-B, Wan G, Yang M-Z, Jiang X-J, Yang J-Y
Department of Urology Surgery, Dalian Municipal Friendship Hospital, Dalian, China.
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9238. doi: 10.26355/eurrev_202009_22996.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137, by J.-G. Liu, H.-B. Wang, G. Wan, M.-Z. Yang, X.-J. Jiang, J.-Y. Yang, published in Eur Rev Med Pharmacol Sci 2019; 23 (13): 5675-5681-DOI: 10.26355/eurrev_201907_18304-PMID: 31298319" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18304.
由于本文被怀疑存在研究不当行为，且通讯作者未回应我们关于证明数据和图表原创性的要求，“J.-G. Liu、H.-B. Wang、G. Wan、M.-Z. Yang、X.-J. Jiang、J.-Y. Yang发表于《欧洲医学与药理学评论》2019年；23(13):5675 - 5681 - DOI: 10.26355/eurrev_201907_18304 - PMID: 31298319的《长链非编码RNA ZFPM2 - AS1通过靶向miR - 137促进肾细胞癌的肿瘤发生》”已被撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/18304
